阿片类药物作用与阿片使用障碍的功能基因组机制:动物模型与人类研究的系统综述
该研究系统检索PubMed、Embase和Web of Science,纳入73篇关于灵长类与啮齿类动物及人类阿片作用全基因组转录组和表观遗传机制的研究。
要点
- 跨研究全基因组结果一致性出乎意料地低,单细胞方法亦如此。
- 异质性来源包括物种、脑区、暴露时长、品系、时间点和批次效应,而非阿片类型。
研究设计与样本
- 系统综述采用前瞻性注册方法,在PubMed、Embase和Web of Science进行综合文献检索,从2709篇文献中纳入73篇进行定性分析。
- 对5个研究最多的神经系统结构(伏隔核、额叶皮层、全纹状体、背侧纹状体、脊髓;44篇文献)的差异表达基因进行定量分析。
主要发现
- 变异来源分析检测到物种、脑结构、阿片暴露时长、品系、分析时间点和批次效应的显著贡献,但未检测到阿片类型的显著贡献。
- 研究利用无阈值方法展示全基因组比较可产生新发现与假设。
关键数值与推荐
- 共识别2709篇文献,73篇符合纳入标准并考虑进行定性分析。
- 5个研究最多的神经系统结构相关文献共44篇。
临床怎么用
- 临床解读阿片相关基因组研究时需考虑物种、脑区、暴露时长、品系、分析时间点和批次效应等异质性来源。
- 跨研究一致性低提示需谨慎对待单基因或单研究结论,无阈值方法可为未来研究提供新假设。
局限性
- 跨研究一致性出乎意料地低,受物种、脑结构、暴露时长、品系、时间点和批次效应显著影响。
- 当前对阿片功能基因组与表观遗传机制的理解仍匮乏。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In the past two decades, over-prescription of opioids for pain management has driven a steep increase in opioid use disorder (OUD) and death by overdose, exerting a dramatic toll on western countries. OUD is a chronic relapsing disease associated with a lifetime struggle to control drug consumption, suggesting that opioids trigger long-lasting brain adaptations, notably through functional genomic and epigenomic mechanisms. Current understanding of these processes, however, remain scarce, and have not been previously reviewed systematically. To do so, the goal of the present work was to synthesize current knowledge on genome-wide transcriptomic and epigenetic mechanisms of opioid action, in primate and rodent species. Using a prospectively registered methodology, comprehensive literature searches were completed in PubMed, Embase, and Web of Science. Of the 2709 articles identified, 73 met our inclusion criteria and were considered for qualitative analysis. Focusing on the 5 most studied nervous system structures (nucleus accumbens, frontal cortex, whole striatum, dorsal striatum, spinal cord; 44 articles), we also conducted a quantitative analysis of differentially expressed genes, in an effort to identify a putative core transcriptional signature of opioids. Only one gene, Cdkn1a, was consistently identified in eleven studies, and globally, our results unveil surprisingly low consistency across published work, even when considering most recent single-cell approaches. Analysis of sources of variability detected significant contributions from species, brain structure, duration of opioid exposure, strain, time-point of analysis, and batch effects, but not type of opioid. To go beyond those limitations, we leveraged threshold-free methods to illustrate how genome-wide comparisons may generate new findings and hypotheses. Finally, we discuss current methodological development in the field, and their implication for future research and, ultimately, better care.
引用
- Falconnier C, Caparros-Roissard A, Decraene C, et al. Functional genomic mechanisms of opioid action and opioid use disorder: a systematic review of animal models and human studies. Mol Psychiatry. 2023. PMID: 37723284. doi:10.1038/s41380-023-02238-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。